Advertisement
Home Tags Cancer: Misc.

Tag: Cancer: Misc.

March 2015 Briefing – Hematology & Oncology

0
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for March 2015. This roundup includes...
America is making slow but steady progress against cancer

Small, Steady Decline in Cancer Rates in U.S. Over Past Decade

0
Annual report shows progress in battle against cancer
A pharmacist-led comprehensive medication assessment shows that a high number of older oncology patients use multiple and/or inappropriate medications. The findings were published online March 23 in the Journal of Clinical Oncology.

Multiple, Inappropriate Meds Taken by Older Cancer Patients

0
A pharmacist-led comprehensive medication assessment can optimize meds
Early initiation of palliative care interventions improves survival and caregiver burden in advanced cancer

Early Palliative Care Improves Survival in Advanced Cancer

0
Second study shows benefits for caregivers with early palliative care intervention
Fit middle-aged men appear less likely to develop lung and colorectal cancer in later life than their out-of-shape peers. And if they do develop cancer

Cancer Risk Down for Men With High Midlife Fitness

0
Study shows lower risk of lung, colon tumors at 65 and older
There is a considerable gap between patient expectations and current practices for provision of information relating to radiation use in medical imaging tests

Patients Expect More Info About Tests Involving Radiation

0
Gap between patient expectations, current practices for provision of information about radiation use
Obesity takes a huge toll on health

Cancer Odds Up 40 Percent in Obese Women

0
However, researchers stress that losing excess weight can lower the odds again
Estimates of cancer incidence for 2011 in the United States show that about two-thirds of those with cancer survive five or more years after diagnosis

CDC Releases Estimates of Cancer Incidence, Survival for 2011

0
Sixty-five percent of those with cancer survived five years or more; survival lower among blacks
Patients with low-risk prostate or breast cancer may have higher or lower odds of getting an unnecessary imaging based on geography

Where You Live May Impact Use of Unnecessary Imaging

0
Doctors tend to order more imaging technologies in the Northeast, researchers found
Unituxin (dinutuximab) has been approved by the U.S. Food and Drug Administration to treat children with high-risk neuroblastoma.

FDA Approves Unituxin for High-Risk Neuroblastoma

0
First approval for a therapy aimed specifically to treat the rare pediatric cancer